The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  • Nature. 1996 Aug 29;382(6594):833-5. doi: 10.1038/382833a0.
E Oberlin  1 ,  A Amara ,  F Bachelerie ,  C Bessia ,  J L Virelizier ,  F Arenzana-Seisdedos ,  O Schwartz ,  J M Heard ,  I Clark-Lewis ,  D F Legler ,  M Loetscher ,  M Baggiolini ,  B Moser
Affiliations
  • 1. Unité d'Immunologie Virale, Institut Pasteur, Paris, France.
Abstract

A putative Chemokine Receptor that we previously cloned and termed LESTR has recently been shown to function as a co-receptor (termed fusin) for lymphocyte-tropic HIV-1 strains. Cells expressing CD4 became permissive to Infection with T-cell-line-adapted HIV-1 strains of the syncytium-inducing phenotype after transfection with LESTR/fusin complementary DNA. We report here the indentification of a human chemokine of the CXC type, stromal cell-derived factor 1 (SDF-1), as the natural ligand for LESTR/fusin, and we propose the term CXCR-4 for this receptor, in keeping with the new chemokine-receptor nomenclature. SDF-1 activates Chinese hamster ovary (CHO) cells transfected with CXCR-4 cDNA as well as blood leukocytes and lymphocytes. In cell lines expressing CXCR-4 and CD4, and in blood lymphocytes, SDF-1 is a powerful inhibitor of Infection by lymphocyte-tropic HIV-1 strains, whereas the CC Chemokines RANTES, MIP-1 Alpha and MIP-1 beta, which were shown previously to prevent Infection with primary, monocyte-tropic viruses, are inactive. In combination with CC Chemokines, which block the Infection with monocyte/macrophage-tropic viruses, SDF-1 could help to decrease virus load and prevent the emergence of the syncytium-inducing viruses which are characteristic of the late stages of AIDS.